HCA Healthcare (NYSE:HCA) had its price objective upped by analysts at Leerink Swann from $105.00 to $120.00 in a report released on Wednesday. The firm currently has an “outperform” rating on the stock. Leerink Swann’s price target suggests a potential upside of 18.62% from the stock’s previous close.
HCA has been the subject of several other research reports. Credit Suisse Group reissued an “outperform” rating and set a $25.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 26th. Robert W. Baird set a $104.00 price objective on HCA Healthcare and gave the company a “buy” rating in a research note on Friday, January 12th. Raymond James Financial cut HCA Healthcare from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, October 18th. Morgan Stanley cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 price objective for the company. in a research note on Wednesday, December 20th. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and issued a $92.00 price objective on shares of HCA Healthcare in a research note on Wednesday, October 4th. Four equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and eighteen have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $99.90.
HCA Healthcare (HCA) traded down $0.29 during mid-day trading on Wednesday, reaching $101.16. The company’s stock had a trading volume of 3,730,000 shares, compared to its average volume of 2,350,000. The company has a debt-to-equity ratio of -6.46, a quick ratio of 1.41 and a current ratio of 1.68. The firm has a market capitalization of $36,540.00, a PE ratio of 17.03, a price-to-earnings-growth ratio of 1.27 and a beta of 0.55. HCA Healthcare has a one year low of $71.18 and a one year high of $106.84.
In related news, insider Michael S. Cuffe sold 2,400 shares of HCA Healthcare stock in a transaction on Friday, December 15th. The stock was sold at an average price of $86.63, for a total value of $207,912.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Joseph A. Sowell III sold 58,175 shares of HCA Healthcare stock in a transaction on Friday, January 26th. The shares were sold at an average price of $95.00, for a total value of $5,526,625.00. Following the completion of the transaction, the senior vice president now owns 40,536 shares of the company’s stock, valued at $3,850,920. The disclosure for this sale can be found here. Over the last quarter, insiders sold 78,725 shares of company stock valued at $7,132,797. 2.90% of the stock is currently owned by company insiders.
Large investors have recently added to or reduced their stakes in the stock. Atlantic Trust LLC purchased a new position in HCA Healthcare in the second quarter valued at $118,000. BB&T Investment Services Inc. purchased a new position in HCA Healthcare in the second quarter valued at $141,000. D.A. Davidson & CO. boosted its holdings in HCA Healthcare by 37.7% in the second quarter. D.A. Davidson & CO. now owns 1,970 shares of the company’s stock valued at $171,000 after purchasing an additional 539 shares during the period. Massey Quick Simon & CO. LLC purchased a new position in HCA Healthcare in the third quarter valued at $251,000. Finally, Parametrica Management Ltd purchased a new position in HCA Healthcare in the third quarter valued at $299,000. Hedge funds and other institutional investors own 75.23% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece was first published by American Banking and Market News and is the property of of American Banking and Market News. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2018/01/31/leerink-swann-raises-hca-healthcare-hca-price-target-to-120-00.html.
HCA Healthcare Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
